Postdoctoral Position Available

Organization
Icahn School of Medicine at Mount Sinai
Job Location
New York, NY 10029
Job Description

We hope to add a driven, resourceful individual to our team at the Azeloglu Lab in the Department of Pharmacological Sciences at Mount Sinai. We are a multidisciplinary group studying systems-level characteristics of cellular mechanobiology using a wide variety of biological and engineering methods. Projects may range from biophysical fingerprinting of drug toxicity to multi-omics screening of new drug targets for nephropathy. All team members are expected to get their hands dirty with both the experimental and computational aspects of the work. The ideal individual should have a PhD in biological/biomedical sciences or bioengineering, and should value curiosity and critical thinking just as much as technical prowess as a bench scientist. Some key aspects that would undoubtedly help:

-        Experience in molecular and cellular biology techniques

-        Deep understanding of cell signaling and cell-cell communication, especially pathways associated with mechanobiology

-        Bonus: knowledge of next-generation sequencing or proteomics

-        Bonus: experience with in vitro or animal models of human disease

-        Brownie points: knowledge of kidney biology and physiology

Icahn School of Medicine at Mount Sinai is part of an internationally acclaimed health system located at the heart of New York City. We are committed to promoting diversity, equal opportunity, and affirmative action at all levels, and we strongly encourage applications from women, individuals with disabilities, and members of underrepresented groups. 

How to Apply

If interested, please email evren.azeloglu(at)mssm.edu. You can get more information on our science at:

 https://scholar.google.com/citations?user=iRptAiwAAAAJ&hl=en&oi=ao

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.